Oklahoma Cancer Specialists and Research Institute

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz et al. · New England Journal of Medicine · 2023 · 718 citations · Full text

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

Kathleen N. Moore, Michael A. Bookman, Jalid Sehouli et al. · Journal of Clinical Oncology · 2021 · 376 citations · Full text

Roentgenographic Evaluation of Lumbar Spine Flexion-Extension in Asymptomatic Individuals

MARK A. HAYES, Thomas C. Howard, Curtis R. Gruel et al. · Spine · 1989 · 292 citations

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 272 citations · Full text

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

Sumanta K. Pal, Catherine M. Tangen, Ian M. Thompson et al. · The Lancet · 2021 · 266 citations · Full text

Urology, Genitourinary Cancer, Medicine +6